Medicare AdvantagePrior AuthMedium impact
Duexis (ibuprofen-famotidine) (Revised)
Humana·Rheumatology, Orthopedics, Pain Management +2 more·Medicare Advantage
Effective date
Jan 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage now requires prior authorization for Duexis (ibuprofen-famotidine) tablets effective January 1, 2026. Members must have tried two different prescription NSAID plus H2-receptor antagonist combinations before approval for rheumatoid arthritis or osteoarthritis treatment.
Action Required
By January 1, 2026: Billing team must update prior authorization system to require approval for all Duexis (ibuprofen-famotidine) prescriptions for Humana Medicare Advantage members. Providers must document that patient has previously failed two different combinations of prescription NSAID plus H2-receptor antagonist before prescribing. Claims will be denied without prior authorization approval.